• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Panjon Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3368.0
  • ISIN : INE744D01019
22.40 0 (-1.93%)
  • As on 06 Sep 2026 (EOD)

  • Today’s Low

    21.10

  • Today’s High

    22.84

  • Open

    21.50

  • Perv Close

    22.84

  • 52W Low

    16.10

  • 52W High

    30.00

Key Indicators

  • P/E(TTM)

    62.22

  • Mar.Cap (₹Cr.)

    38.45

  • Div & Yield %

    0.00

  • Book Value(₹)

    9.92

  • Debt-Equity Ratio

    -1.93

  • AGM Date

    04-Sep-2026

  • EPS

    0.36

  • P/E Ratio

    62.22

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    38.45

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    17.16

  • BV (₹)

    9.90

  • Sales( ₹ in Cr.)

    47.62

  • NP (in Cr.)

    0.60

  • NP Var(%)

    51.0

  • Div%

    0.0

  • CPS (₹)

    0.50

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    38.45

  • 52 Week High

    30.00

  • 52 Week Low

    16.10

  • Price BSE

    22.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    38.45

  • P/C Ratio

    41.80

  • P/E Ratio

    62.90

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 30.46 12.55 6.09 8.43 14.54 26.43
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 30.46 12.55 6.09 8.43 14.54 26.43
Other Income 0.31 0.45 0.38 0.30 0.33 0.29
Stock Adjustments 0.27 0.21 -0.10 0.05 -0.08 0.07
Total Income 31.04 13.21 6.37 8.78 14.79 26.79
EXPENDITURE :            
Raw Materials 25.87 9.17 1.98 4.54 11.68 23.60
Power and Fuel Cost 0.08 0.07 0.07 0.08 0.10 0.16
Employee Cost 0.70 0.60 0.47 0.46 0.42 0.47
Other Manufacturing Expenses 0.02 0.02 0.03 0.02 0.18 0.28
Selling and Administration Expenses 3.11 2.69 3.15 3.05 1.50 1.52
Miscellaneous Expenses 0.31 0.22 0.30 4.38 0.39 0.14
Employee Benefit Expenses 0.70 0.60 0.47 0.46 0.42 0.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 30.08 12.77 6.00 12.52 14.27 26.18
Operating Profit 0.94 0.43 0.38 -3.74 0.52 0.61
Interest 0.18 0.06 0.05 0.07 0.10 0.15
Gross Profit 0.76 0.37 0.33 -3.81 0.42 0.46
Depreciation 0.23 0.22 0.21 0.20 0.23 0.27
Profit Before Tax 0.53 0.15 0.12 -4.01 0.19 0.19
Current Tax 0.08 0.02 0.02 0.02 0.02 0.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 -0.02 -0.71 0.12 0.07 0.18
Reported Net Profit 0.40 0.15 0.81 -4.15 0.10 -0.03
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.40 0.15 0.81 -4.15 0.10 -0.03
Adjustment below Net Profit 0.01 0.00 0.01 0.00 -0.01 -0.01
P & L Balance brought forward -10.34 -10.50 -11.32 -7.17 -7.25 -7.21
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -9.93 -10.34 -10.50 -11.32 -7.17 -7.25
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.23 0.09 0.52 -2.68 0.06 -0.02
Earnings Per Share(Adj)-Unit Curr 0.23 0.09 0.52 -2.68 - -
Book Value 9.64 9.11 8.70 8.17 10.85 10.79
Book Value(Adj)-Unit Curr 9.64 9.11 8.70 8.17 - -

Shareholding Pattern

  • Promoter Group

    56.69%

  • Public Share Holding

    43.31%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,500,000 8.74 1,500,000 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,229,815 47.95 8,229,815 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,729,815 56.69 9,729,815 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 932,437 5.43 932,037 54
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 130,482 0.76 89,782 513
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 215,716 1.26 215,716 139
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,447,021 14.26 2,447,021 27
Individuals holding nominal share capital up to Rs. 1 lakh 3,694,251 21.52 3,393,088 9,630
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,000 0.01 2,000 2
Others 0 0.00 0 0
Sub Total 7,434,711 43.31 7,092,448 10,371
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 17,164,526 100.00 16,822,263 10,380

Company Background

Panjon LtdPharmaceuticals - Indian - Formulations

  • Panjon Ltd
  • BSE Code : 3368.0
  • ISIN : INE744D01019

  • Incorporation Year

    1983

  • Registered Office

    01 Panjon Farm House
    Airport Bijasan Road, Indore,
    Madhya Pradesh-452005

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Jay Kothari

  • Company Secretary

    Arpita Vijayvargiya

  • Auditor

    Goyal Parul & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Panjon Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Panjon 22.40 30.77 30.46 62.22 2.55
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 393.10 354.33 41.34 15.94
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77